Siekierka J - Search Results

1

Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.

Wei S, Daniel BJ, Brumlik MJ, Burow ME, Zou W, Khan IA, Wadsworth S, Siekierka J, Curiel TJ. Wei S, et al. Among authors: siekierka j. Antimicrob Agents Chemother. 2007 Dec;51(12):4324-8. doi: 10.1128/AAC.00680-07. Epub 2007 Oct 8. Antimicrob Agents Chemother. 2007. PMID: 17923491 Free PMC article.

2

Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.

Brumlik MJ, Nkhoma S, Kious MJ, Thompson GR 3rd, Patterson TF, Siekierka JJ, Anderson TJ, Curiel TJ. Brumlik MJ, et al. Among authors: siekierka jj. Exp Parasitol. 2011 Jun;128(2):170-5. doi: 10.1016/j.exppara.2011.02.016. Epub 2011 Feb 19. Exp Parasitol. 2011. PMID: 21338604 Free PMC article.

3

p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells.

Schafer PH, Wadsworth SA, Wang L, Siekierka JJ. Schafer PH, et al. Among authors: siekierka jj. J Immunol. 1999 Jun 15;162(12):7110-9. J Immunol. 1999. PMID: 10358155

4

Imidazopyrimidines, potent inhibitors of p38 MAP kinase.

Rupert KC, Henry JR, Dodd JH, Wadsworth SA, Cavender DE, Olini GC, Fahmy B, Siekierka JJ. Rupert KC, et al. Among authors: siekierka jj. Bioorg Med Chem Lett. 2003 Feb 10;13(3):347-50. doi: 10.1016/s0960-894x(02)01020-x. Bioorg Med Chem Lett. 2003. PMID: 12565927

5

Kinetics of small molecule inhibitor binding to p38 kinase.

Thurmond RL, Wadsworth SA, Schafer PH, Zivin RA, Siekierka JJ. Thurmond RL, et al. Among authors: siekierka jj. Eur J Biochem. 2001 Nov;268(22):5747-54. doi: 10.1046/j.0014-2956.2001.02512.x. Eur J Biochem. 2001. PMID: 11722559 Free article.

6

T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.

Schafer PH, Wang L, Wadsworth SA, Davis JE, Siekierka JJ. Schafer PH, et al. Among authors: siekierka jj. J Immunol. 1999 Jan 15;162(2):659-68. J Immunol. 1999. PMID: 9916683

7

Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor.

Muthumani K, Wadsworth SA, Dayes NS, Hwang DS, Choo AY, Abeysinghe HR, Siekierka JJ, Weiner DB. Muthumani K, et al. Among authors: siekierka jj. AIDS. 2004 Mar 26;18(5):739-48. doi: 10.1097/00002030-200403260-00004. AIDS. 2004. PMID: 15075508

8

Potent inhibitors of the MAP kinase p38.

Henry JR, Rupert KC, Dodd JH, Turchi IJ, Wadsworth SA, Cavender DE, Schafer PH, Siekierka JJ. Henry JR, et al. Among authors: siekierka jj. Bioorg Med Chem Lett. 1998 Dec 1;8(23):3335-40. doi: 10.1016/s0960-894x(98)00589-7. Bioorg Med Chem Lett. 1998. PMID: 9873730

9

Inhibitors of unactivated p38 MAP kinase.

Bullington J, Argentieri D, Averill K, Carter D, Cavender D, Fahmy B, Fan X, Hall D, Heintzelman G, Jackson P, Leung WP, Li X, Ling P, Olini G, Razler T, Reuman M, Rupert K, Russell R, Siekierka J, Wadsworth S, Wolff R, Xiang B, Zhang YM. Bullington J, et al. Among authors: siekierka j. Bioorg Med Chem Lett. 2006 Dec 1;16(23):6102-6. doi: 10.1016/j.bmcl.2006.08.101. Epub 2006 Sep 12. Bioorg Med Chem Lett. 2006. PMID: 16971122

10

RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Wachter MP, Siekierka JJ. Wadsworth SA, et al. Among authors: siekierka jj. J Pharmacol Exp Ther. 1999 Nov;291(2):680-7. J Pharmacol Exp Ther. 1999. PMID: 10525088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters